Genetics Meets Therapy? Exome-wide Association Study Reveals a Loss-of-Function Variant in 17-Beta-Hydroxysteroid Dehydrogenase 13 That Protects Patients From Liver Damage and Nonalcoholic Fatty Liver Disease Progression

Sookoian, Silvia Cristina; Arrese, Marco; Pirola, Carlos José

doi:10.1002/hep.30209

Artículo

Genetics Meets Therapy? Exome-wide Association Study Reveals a Loss-of-Function Variant in 17-Beta-Hydroxysteroid Dehydrogenase 13 That Protects Patients From Liver Damage and Nonalcoholic Fatty Liver Disease Progression

Sookoian, Silvia Cristina Icon

; Arrese, Marco; Pirola, Carlos José Icon

Fecha de publicación: 02/2019

Editorial: John Wiley & Sons Inc

Revista: Hepatology (Baltimore, Md.)

ISSN: 0270-9139

Idioma: Inglés

Tipo de recurso: Artículo publicado

Clasificación temática:

Genética Humana; Gastroenterología y Hepatología

Palabras clave: NASH , TREATMENT , GENETICS , HSD17B13

Ver el registro completo

Archivos asociados

Tamaño: 346.2Kb

Formato: PDF

Solicitar

Licencia

Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)

Identificadores

URI: http://hdl.handle.net/11336/117945

URL: https://aasldpubs.onlinelibrary.wiley.com/doi/abs/10.1002/hep.30209

DOI: http://dx.doi.org/10.1002/hep.30209

Colecciones

Articulos(IDIM)
Articulos de INST.DE INVEST.MEDICAS

Citación

Sookoian, Silvia Cristina; Arrese, Marco; Pirola, Carlos José; Genetics Meets Therapy? Exome-wide Association Study Reveals a Loss-of-Function Variant in 17-Beta-Hydroxysteroid Dehydrogenase 13 That Protects Patients From Liver Damage and Nonalcoholic Fatty Liver Disease Progression; John Wiley & Sons Inc; Hepatology (Baltimore, Md.); 69; 2; 2-2019; 907-910

Altmétricas